Product Information

PHENOBARBITAL 30 MG TABLET is a generic product labeled by e5 Pharma, LLC, priced at $0.1344 per EA under NDC 13517069201. Its NADAC has been published 185 times since Feb 8, 2023.

PHENOBARBITAL 30 MG TABLET

phenobarbital
$0.1344per EA
DEA Schedule CIV

Strength

30 mg/1

Manufacturer

e5 Pharma, LLC

NDC

13517069201

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PHENOBARBITAL

Approval Type

Unapproved

On Market Since

11/30/2022

Price Statistics

The NADAC for PHENOBARBITAL 30 MG TABLET has been published 185 times since Feb 8, 2023, and over the history we have for it it has declined 29.8%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1344 per EA
All-time high$0.2172 (Jul 12, 2023)
All-time low$0.0913 (Nov 20, 2024)
52-week high$0.1735
52-week low$0.1206
Median price$0.1546
Average price$0.1527
Largest weekly change-45.1% (Nov 20, 2024)
Weeks tracked185
Tracking sinceFeb 8, 2023

Price History

1W

+11.5%

1M

+11.5%

3M

-0.8%

6M

-3.1%

1Y

-22.5%

3Y

-14.5%

5Y

N/A

All

-29.8%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the phenobarbital market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

No related drugs found.

Frequently asked questions

What is the NADAC price of PHENOBARBITAL 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PHENOBARBITAL 30 MG TABLET, manufactured by e5 Pharma, LLC, is $0.1344 per EA (NDC 13517069201), effective Aug 19, 2026.

How has the price of PHENOBARBITAL 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for PHENOBARBITAL 30 MG TABLET has declined 29.8%. It has been tracked across 185 weekly CMS publications since Feb 8, 2023.

What are the highest and lowest recorded NADAC prices for PHENOBARBITAL 30 MG TABLET?

Since Feb 8, 2023, the NADAC for PHENOBARBITAL 30 MG TABLET has ranged from a low of $0.0913 (Nov 20, 2024) to a high of $0.2172 (Jul 12, 2023), with a median of $0.1546 per EA.

Are there cheaper alternatives to PHENOBARBITAL 30 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PHENOBARBITAL 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PHENOBARBITAL 30 MG TABLET?

PHENOBARBITAL 30 MG TABLET (NDC 13517069201) is labeled by e5 Pharma, LLC, and CMS classifies it as a generic product.